Pharmaceuticals Headlines from PR Newswire

< Go Back

Global Animal Health Market 2014 Trends and 2017 Veterinary Health Industry Forecasts Report
Optel Vision EMEA Office officially opened by the Minister of Finance, Mr. Michael Noonan TD
Hovione Files its First Investigational New Drug Application With the FDA
Rheumatoid Arthritis Market Pipeline 2014 H2 Review
Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA
Immune Pharmaceuticals Inc. Completes Underwriter's Exercise Of Partial Over-Allotment Option
Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference
Lexicon Announces Completion Of $280 Million In Financing Transactions
Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference
Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information
Study Published in Nature Suggests immunoSEQ™ Assay May Be Used to Predict Response to anti-PD-1 Therapy for Melanoma
Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares
Empty Capsules Market Worth $1,820 Million by 2019
Breakthrough in Opioid Addiction Treatment Now Covered by Insurance Companies
MEI Pharma To Host Annual Meeting Of Stockholders
Frost & Sullivan Lauds Philips Healthcare's Introduction of Vereos, the First Digital PET/CT Solution
Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance
Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board
CARsgen Completes Series A Financing
Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report
China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results
China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer
Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference
Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants
Jazz Pharmaceuticals Announces Participation in Two Investor Conferences
Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis
Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc.
Array BioPharma To Present At The Piper Jaffray And Oppenheimer 2014 Healthcare Conferences
Neurocrine to Present at the 2014 Deutsche Bank BioFEST and the 26th Annual Piper Jaffray Healthcare Conference
goBalto Selected as a 2014 Red Herring Top 100 Global Company
Developers of Breakthrough Medical Process for Treatment of Opioid Addiction Achieve Federal Certification
The Rising Star of the Healthcare Industry in China
Dr. J. Murray Hockings Puts Thousands on a Natural Path to Becoming Clinically Non-Diabetic
Researchers Report Thymosin Beta 4 is Cardioprotective in Pulmonary Hypertension/Heart Failure Model
Global Neuroprosthetics Market is Expected to Reach $14 Billion by 2020 - Allied Market Research
Stock Updates on Pharma Services - Avanir Pharma, Zoetis, Allergan, Mallinckrodt, and Actavis
Black Friday Shoppers Will Discover Huge Deals on Holiday Gifts and Everyday Essentials at CVS/pharmacy
Arena Pharmaceuticals Issued Composition of Matter Patent by United States Patent and Trademark Office for Ralinepag and Related Compounds
Xencor to Present at the 2014 Deutsche Bank BioFEST Conference
Valeant Pharmaceuticals Announces FDA Approval Of ONEXTON™ Gel For The Treatment Of Acne Vulgaris
Mylan Confirms First-to-File Patent Challenge Relating to BREVIBLOC®
BioDelivery Sciences to Present at the 26th Annual Piper Jaffray Healthcare Conference
Small Cap IR Issues Tenax Therapeutics Analyst Report: Large Validated Market Opportunity Inspires $12 Price Target
Parent Project Muscular Dystrophy and Santhera Pharmaceuticals Team Up on Benefit/Risk Study in Duchenne
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Children With Spinal Muscular Atrophy Announces Distribution of Reports by QYResearch Group
Apitope Receives Orphan Designation in the European Union for ATX-F8-117 for the Treatment of Haemophilia A Announces Distribution of DelveInsight Research
Synthetic Biology Market Growth Analysis and 2018 Worldwide Forecasts

< Prev Next >
PR Newswire - United Business Media